In Chevron's Fall, Attys See Conflicting Rulings, Circuit Splits
The end of Chevron deference, along with other U.S. Supreme Court decisions weakening the authority of federal agencies, may make the drug regulatory landscape more volatile — not less — as...To view the full article, register now.
Already a subscriber? Click here to view full article